Patents by Inventor Andreas Schwienhorst

Andreas Schwienhorst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7423021
    Abstract: The invention relates to biologically active molecules, which interact with and inhibit thrombin. The invention particularly relates to molecules of general formula (I): Y1—(NH—X1—CO)—(NH—X2—C?O)—(NH—X3—C?O)—(NH—X.sup.4—C?O)—(NH—X6—C?O) (NH—X6—C?O)—Y2, wherein the compound can be used for thrombin inhibition, inhibition of fibrin formation, and/or for the inhibition of the formation of a clot. Compounds disclosed herein can also be used for treatingm, diagnosing, and prophylaxis of thrombotic disorders.
    Type: Grant
    Filed: January 15, 2004
    Date of Patent: September 9, 2008
    Assignee: NSCI Novel Science International GmbH
    Inventors: Marcel Thurk, Andreas Schwienhorst
  • Publication number: 20060172407
    Abstract: The invention relates to the use of substances which bind to the bacterial elongation factor EF-Tru for cell digestion or for the lysis of cells. The invention further relates to a cell digestion system and a cell digestion method.
    Type: Application
    Filed: July 2, 2003
    Publication date: August 3, 2006
    Inventors: Frank Mayer, Andreas Schwienhorst
  • Publication number: 20060105959
    Abstract: The invention relates to biologically active molecules, which interact with thrombin and inhibit the same. The invention particularly relates to molecules of general fomula (I): Y1—(NH—X1—C?O)—(NH—X2—C?O)—(NH—X3—C?O)—(NH—X4—C?O)—(NH—X6—C?O) (NH—X6—C?O)—Y2, wherein Y1, Y2 and X1-6 have the meanings given in the description and N- or C-terminal abbreviated variations of said compounds and the use thereof for the production of medicaments.
    Type: Application
    Filed: January 15, 2004
    Publication date: May 18, 2006
    Applicant: CPI CREATIVE PHARMA INTERNATIONAL GMBH
    Inventors: Marcel Thurk, Andreas Schwienhorst
  • Patent number: 7015017
    Abstract: A process for instabilizing viral quasi-species-distributions under avoidance of resistance phenomena by replication of the nucleic acids of the viruses present in the quasi-species-distribution by of a defective replication system, a) whereby the defective replication system has a rate of misincorporation for nucleotides above the rate of misincorporation of the viral wild-type-replication system and, whereby the viruses are replicated by the replication system having the higher rate of misincorporation at least as effectively as it is done by the replication system of the wild-type virus, b) and/or negative influence of the replication of the consensus-sequence (nucleic acid sequence of the wild-type virus) in relation to other replicatable nucleic acids.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: March 21, 2006
    Assignee: Evotec Biosystems AG
    Inventors: Manfred Eigen, Andreas Schwienhorst, Christof Biebricher, Björn Lindemann, Esteban Domingo, John Holland, Karsten Henco
  • Publication number: 20020107220
    Abstract: A process for instabilizing viral quasi-species-distributions under avoidance of resistance phenomena by replication of the nucleic acids of the viruses present in the quasi-species-distribution by of a defective replication system,
    Type: Application
    Filed: October 25, 2001
    Publication date: August 8, 2002
    Applicant: EVOTECH BIOSYSTEMS AG
    Inventors: Manfred Eigen, Andreas Schwienhorst, Christof Biebricher, Bjorn Lindemann, Esteban Domingo, John Holland, Karsten Henco
  • Patent number: 6423516
    Abstract: A process for instabilizing viral quasi-species-distributions under avoidance of resistance phenomena by replication of the nucleic acids of the viruses present in the quasi-species-distribution by of a defective replication system, a) whereby the defective replication system has a rate of misincorporation for nucleotides above the rate of misincorporation of the viral wild-type-replication system and, whereby the viruses are replicated by the replication system having the higher rate of misincorporation at least as effectively as it is done by the replication system of the wild-type virus, b) and/or negative influence of the replication of the consensus-sequence (nucleic acid sequence of the wild-type virus) in relation to other replicatable nucleic acids.
    Type: Grant
    Filed: March 22, 1996
    Date of Patent: July 23, 2002
    Assignee: Evotec BioSystems AG
    Inventors: Manfred Eigen, Andreas Schwienhorst, Christof Biebricher, Björn Lindemann, Esteban Domingo, John Holland, Karsten Henco